BRIEF-Hoth Therapeutics Plans To Advance HT-ALZ Into Clinical Development

Reuters
02 Apr
BRIEF-<a href="https://laohu8.com/S/HOTH">Hoth Therapeutics</a> Plans To Advance HT-ALZ Into Clinical Development

April 2 (Reuters) - Hoth Therapeutics Inc HOTH.O:

  • HOTH THERAPEUTICS ANNOUNCES POSITIVE PRE CLINICAL DATA HT-ALZ SHOWS PROMISING BREAKTHROUGH IN ALZHEIMER'S DISEASE RESEARCH ACUTE TREATMENT WITH HT-ALZ LED TO A RAPID (~15%) REDUCTION IN BRAIN INTERSTITIAL FLUID AΒ LEVELS, WITHIN 20 HOURS

  • HOTH THERAPEUTICS - PLANS TO ADVANCE HT-ALZ INTO CLINICAL DEVELOPMENT

Source text: ID:nPnbTk1V8a

Further company coverage: HOTH.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10